LIQUID CRYSTAL SENSOR SYSTEM

• US 20070099306A1
• Filed: 09/27/2006
• Published: 05/03/2007
• Est. Priority Date: 09/28/2005
• Status: Abandoned Application

• Current Assignee: Kent State University
• Original Assignee: Kent State University
• Inventors: WOOLVERTON, Christopher
• Application Number:
  US11/535,541
• Publication Number:
  US 20070099306A1
• Time in Patent Office: Days
• US Class Current: 436/518
• CPC Class Codes: B01L 3/5027 by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip B01L3/5023 takes precedence; micromixers B01F33/30; microreactors for synthesis B01J19/0093; microcapillary devices in general B81B1/00
• CPC Class Codes: G01N 33/5438 Electrodes

Abstract

A method of detecting a ligand comprises providing a receptor for a predetermined ligand. The receptor comprises a conductive material. The receptor is contacted with a sample in the presence of a non-conductive medium. When the ligand is present in the sample, the receptor and the ligand form a receptor-ligand complex that is capable of forming a conductive aggregate. A second receptor is then provided. The second receptor is a receptor for the conductive aggregate, and the second receptor is bound to a pair of electrodes. The electrodes are electrically separated from each other in the absence of the conductive aggregate, and are electrically communicating in the presence of conductive aggregates. The method also includes providing a power source in electrical communication with the electrodes, such that an electric circuit is selectively completed in the presence of conductive aggregates, signaling the detection and capture of the ligand. A cassette for performing this method is also provided.

Claims

1. A method of detecting a ligand, the method comprising:

providing a first receptor, wherein the first receptor is a receptor for at least one predetermined ligand, and wherein the first receptor is coated with an electrically conductive material;

contacting the receptor with a sample to be tested, in the presence of a non-conductive medium, wherein the receptor and the at least one predetermined ligand, when present in the sample, form a receptor-ligand complex, and wherein the receptor-ligand complex and at least one other ligand form a conductive aggregate;

providing a second receptor, wherein the second receptor is a receptor for the conductive aggregate, and wherein the second receptor is bound to a pair of electrodes; and

providing a power source in electrical communication with the electrodes, such that an electrical circuit is selectively completed in the presence of conductive aggregates, signaling the detection and capture of the ligand.

2. The method of claim 1, wherein the non-conductive medium is non-denaturing of biological materials.

3. The method of claim 2, wherein the medium is a liquid crystalline material.

4. The method of claim 3, wherein the liquid crystalline material is a lyotropic liquid crystalline material.

5. The method of claim 3, wherein the liquid crystalline material is a thermotropic liquid crystalline material.

6. The method of claim 1, wherein the first and second receptors are antibodies.

7. The method of claim 1, wherein the pair of electrodes are electrically separated from each other in the absence of the conductive aggregate, and are electrically communicating in the presence of conductive aggregates.

8. A functional cassette for the detection of ligands comprising:

at least one area for receiving a sample to be tested for the presence of one or more ligands, wherein a first receptor is present in the sample receiving area in a non-conductive medium, and wherein each first receptor is a receptor for a predetermined ligand, and further wherein each first receptor is coated with a conductive material and is capable of forming a receptor-ligand complex, and the receptor-ligand complex and at least one other ligand are capable of forming at least one conductive aggregates;

one or more transport areas in separate fluid communication with each of the sample receiving areas and a corresponding detection area, wherein the conductive aggregates are capable of being transported to the corresponding detection area,

wherein each detection area comprises a pair of electrodes and a second receptor bound to the pair of electrodes, and wherein the second receptor is a receptor for the conductive aggregates; and

wherein the electrodes may be placed in electrical communication with a power source such that completion of an electric circuit signals the detection and capture of the predetermined ligand.

9. The cassette of claim 8, wherein the pair of electrodes are electrically separated from each other in the absence of the conductive aggregate and are electrically communicating in the presence of conductive aggregate.

10. The method of claim 8, wherein the non-conductive medium is non-denaturing of biological materials.

11. The method of claim 10, wherein the medium is a liquid crystalline material.

12. The method of claim 11, wherein the liquid crystalline material is a lyotropic liquid crystalline material.

13. The method of claim 11, wherein the liquid crystalline material is a thermotropic liquid crystalline material.

14. The method of claim 8, wherein the first and second receptors are antibodies.

15. A functional cassette having a plurality of channels for the detection of ligands, each channel of the cassette comprising:

a first front portion, wherein the front portion includes a sample application region for a sample to be tested for the presence of one or more ligands, wherein a first receptor is present in the first front portion in a non-conductive medium, and wherein each first receptor is a receptor for a predetermined ligand, and further wherein each first receptor is coated with a conductive material and is capable of forming a receptor-ligand complex, and the receptor-ligand complex and at least one other ligand are capable of forming at least one conductive aggregates;

a second middle portion, wherein an area from the first front portion to the second middle portion define a transport area that includes a primary detection area for receptor-ligand complexes and conductive aggregates, wherein the primary detection area includes a pair of electrodes and a second receptor bound to the pair of electrodes, and wherein the second receptor is a receptor for the conductive aggregates, and wherein the electrodes are placed in electrical communication with a power source such that completion of an electric circuit produces an electrical signal that indicates the detection and capture of the predetermined ligand; and

a third end portion, wherein the third end portion includes an area for signal amplification of the electrical signal.

16. The cassette of claim 15, wherein the first front portion, second middle portion and third end portion are in fluid communication with each other.

17. The cassette of claim 15, wherein the pair of electrodes are electrically separated from each other in the absence of the conductive aggregate and are electrically communicating in the presence of conductive aggregate.

18. The cassette of claim 15, wherein the electrical signal is amplified by a transistor.

19. The method of claim 15, wherein the non-conductive medium is non-denaturing of biological materials.

20. The method of claim 19, wherein the medium is a liquid crystalline material.